Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer.
Carola C, Ghiringhelli F, Kim S, André T, Barlet J, Bengrine-Lefevre L, Marijon H, Garcia-Larnicol ML, Borg C, Dainese L, Steuer N, Richa H, Benetkiewicz M, Larsen AK, de Gramont A, Chibaudel B. Carola C, et al. Among authors: de gramont a. World J Clin Oncol. 2018 Sep 14;9(5):110-118. doi: 10.5306/wjco.v9.i5.110. World J Clin Oncol. 2018. PMID: 30254966 Free PMC article.
EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies.
Poindessous V, Ouaret D, El Ouadrani K, Battistella A, Mégalophonos VF, Kamsu-Kom N, Petitprez A, Escargueil AE, Boudou P, Dumont S, Cervera P, Fléjou JF, André T, Tournigand C, Chibaudel B, de Gramont A, Larsen AK. Poindessous V, et al. Among authors: de gramont a. Clin Cancer Res. 2011 Oct 15;17(20):6522-30. doi: 10.1158/1078-0432.CCR-11-1607. Epub 2011 Aug 31. Clin Cancer Res. 2011. PMID: 21880790
The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.
Rocca CJ, Poindessous V, Soares DG, Ouadrani KE, Sarasin A, Guérin E, de Gramont A, Henriques JA, Escargueil AE, Larsen AK. Rocca CJ, et al. Among authors: de gramont a. Biochem Pharmacol. 2010 Aug 1;80(3):335-43. doi: 10.1016/j.bcp.2010.04.012. Epub 2010 Apr 22. Biochem Pharmacol. 2010. PMID: 20399198
Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
Coudray AM, Louvet C, Kornprobst M, Raymond E, André T, Tournigand C, Faivre S, De Gramont A, Larsen AK, Gespach C. Coudray AM, et al. Among authors: de gramont a. Int J Oncol. 2005 Aug;27(2):553-61. Int J Oncol. 2005. PMID: 16010439
Targeted agents for adjuvant therapy of colon cancer.
de Gramont A, Tournigand C, André T, Larsen AK, Louvet C. de Gramont A, et al. Semin Oncol. 2006 Dec;33(6 Suppl 11):S42-5. doi: 10.1053/j.seminoncol.2006.10.006. Semin Oncol. 2006. PMID: 17178286 Review.
Adjuvant therapy for stage II and III colorectal cancer.
de Gramont A, Tournigand C, André T, Larsen AK, Louvet C. de Gramont A, et al. Semin Oncol. 2007 Apr;34(2 Suppl 1):S37-40. doi: 10.1053/j.seminoncol.2007.01.004. Semin Oncol. 2007. PMID: 17449351
400 results